Related Experiment Video

Updated: Aug 8, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation

M D Schneider, M B Perryman, P A Payne

    Molecular and Cellular Biology
    |May 1, 1987
    PubMed

    Insights

    Introducing exogenous c-myc into muscle cells partially blocked differentiation markers. However, it did not prevent muscle cell differentiation when growth factors were withdrawn.

    Area of Science:

    • Molecular Biology
    • Cell Biology
    • Developmental Biology

    Background:

    • Myogenic differentiation requires cell cycle withdrawal and is inhibited by growth factors.
    • The role of c-myc in regulating myogenesis remains incompletely understood.

    Purpose of the Study:

    • To investigate the role of c-myc in the control of muscle cell differentiation (myogenesis).

    Main Methods:

    • Stable transfection of BC3H1 muscle cells with a simian virus 40 promoter:c-myc chimeric gene.
    • Quantification of exogenous and endogenous c-myc expression under varying serum conditions.
    • Analysis of muscle creatine kinase and nicotinic acetylcholine receptor expression.

    Main Results:

    • Exogenous c-myc expression was significantly elevated in transfected cells compared to endogenous c-myc in parental cells.
    • The introduced c-myc partially inhibited key muscle differentiation markers, muscle creatine kinase and nicotinic acetylcholine receptor.
    • Despite partial inhibition, muscle differentiation still occurred upon mitogen withdrawal.

    Conclusions:

    • Overexpression of c-myc alone is insufficient to completely block myogenesis.
    • c-myc plays a regulatory role in myogenesis but does not act as a complete inhibitor of differentiation.
    • Further research is needed to elucidate the complex interplay between c-myc and myogenic regulatory factors.

    More Related Videos

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

    Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

    Published on: February 21, 2018

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

    Inducible and Reversible Dominant-negative (DN) Protein Inhibition

    Published on: January 7, 2019

    Related Concept Videos

    Master Transcription Regulators02:23

    Master Transcription Regulators

    Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    Induced Pluripotent Stem Cells01:06

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
    Somatic cells are...
    Somatic to iPS Cell Reprogramming01:29

    Somatic to iPS Cell Reprogramming

    Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...